Pathogenesis of Primary Biliary Cirrhosis

Clinics in Liver Disease

Volumn 12, Issue 2, 2008, Pages 305-321

  Jones, David E J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN M; TOLL LIKE RECEPTOR;

AUTOIMMUNE DISEASE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; HERITABILITY; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; LIVER TRANSPLANTATION; PATHOGENESIS; PLANT GROWTH; POSTOPERATIVE CARE; PRIMARY BILIARY CIRRHOSIS; RECURRENT DISEASE; REVIEW; SEX RATIO; T LYMPHOCYTE;

HUMANS; LIVER CIRRHOSIS, BILIARY; RISK FACTORS;

EID: 43049101087     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2008.02.004     Document Type: Review

References (74)

1. Mackay I.R. Primary biliary cirrhosis showing a high titre of autoantibody: report of a case study. N Engl J Med 258 (1958) 185-188
2. Yeaman S.J., Fussey S.P., Danner D.J., et al. Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens. Lancet 1 8594 (1988) 1067-1070
3. Jones D.E.J. Pathogensis of primary biliary cirrhosis. Gut 56 (2007) 1615-1624
4. Mutimer D.J., Fussey S.P., Yeaman S.J., et al. Frequency of IgG and IgM autoantibodies to four specific M2 mitochondrial autoantigens in primary biliary cirrhosis. Hepatology 10 (1989) 403-407
5. Kikucki K., Lian Z.X., Yang G.X., et al. Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis. Gastroenterology 128 (2005) 304-312
6. Jones D.E., Watt F.E., Metcalf J.V., et al. Familial primary biliary cirrhosis reassessed: a geographically-based population study. J Hepatol 30 (1999) 402-407
7. Watt F.E., James O.F.W., and Jones D.E.J. Patterns of autoimmunity in PBC patients and their families. QJM 97 (2004) 397-406
8. Lazaridis K.N., Juran B.D., Boe G.M., et al. Increased prevalence of anti-mitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis. Hepatology 46 (2007) 785-792
9. Invernizzi P., Selmi C., Mackay I.R., et al. From bases to basis: linking genetics to causation in primary biliary cirrhosis. Clin Gastroenterol Hepatol 3 (2005) 401-410
10. Liermann Garcia R.F., Evangalista Garcia C., McMaster P., et al. Transplantation for primary biliary cirrhosis:retrospective analysis of 400 patients in a single centre. Hepatology 33 (2001) 22-27
11. Joplin R., Johnson G.D., Matthews J.B., et al. Distribution of pyruvate dehydrogenase dihydrolipoamide acetyltransferase (PDC-E2) and another mitochondrial marker in salivary gland and biliary epithelium from patients with primary biliary cirrhosis. Hepatology 19 (1994) 1375-1380
12. Palmer J.M., Kirby J.A., and Jones D.E.J. The immunology of primary biliary cirrhosis: the end of the beginning. Clin Exp Immunol 129 (2002) 191-197
13. Yeaman S.J., Kirby J.A., and Jones D.E.J. Autoreactive responses to pyruvate dehydrogenase complex in the pathogenesis of primary biliary cirrhosis. Immunol Rev 174 (2000) 238-249
14. Van de Water J., Fregeau D., Davis P., et al. Autoantibodies of primary biliary cirrhosis recognise dihydrolipoamide acetyltransferase and inhibit enzyme function. J Immunol 141 (1988) 2321-2324
15. Palmer J.M., Jones D.E.J., Quinn J., et al. Characterisation of the autoantibody responses to recombinant E3 binding protein (protein X) of pyruvate dehydrogenase in primary biliary cirrhosis. Hepatology 30 (1999) 21-26
16. Quinn J., Diamond A.G., Palmer J.M., et al. Lipoylated and unlipoylated domains of human PDC-E2 as autoantigens in primary biliary cirrhosis: significance of lipoate attachment. Hepatology 18 (1993) 1384-1391
17. Koike K., Ishbashi H., and Koike M. Immunoreactivity of porcine heart dihydrolipoamide acetyl- and succinyl-transferases (PDC-E2, OGDC-E2) with primary biliary cirrhosis sera: characterisation of the autoantigenic region and effects of enzymatic delipoylation and relipoylation. Hepatology 27 (1998) 1467-1474
18. Bruggraber S.F., Leung P.S., Amano K., et al. Autoreactivity to lipoate and a conjugated form of lipoate in primary biliary cirrhosis. Gastroenterology 125 (2003) 1705-1713
19. Shimoda S., Nakamura M., Ishibashi H., et al. HLA DRB4 0101-restricted immunodominant T-cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune disease. J Exp Med 181 (1995) 1835-1845
20. Jones D.E.J., Palmer J.M., Yeaman S.J., et al. T-cell responses to the components of pyruvate dehydrogenase complex in primary biliary cirrhosis. Hepatology 21 (1995) 995-1002
21. Shimoda S., Van de Water J., Ansari A., et al. Identification and precursor frequency analysis of a common T-cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. J Clin Invest 102 (1998) 1831-1840
22. Kita H., Matsumura S., He X., et al. Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. J Clin Invest 109 (2002) 1231-1240
23. Kita H., Lian Z., Van de Water J., et al. Identification of HLA-A2-restricted CD8+ cytotoxic T-cell responses in primary biliary cirrhosis: T-cell activation is augmented by immune complexes cross-presented by dendritic cells. J Exp Med 195 (2002) 113-123
24. Robe A.J., Kirby J., Jones D.E.J., et al. A Key role for autoreactive B-cells in the breakdown of T-cell tolerance to pyruvate dehydrogenase complex. Hepatology 41 (2005) 1106-1112
25. Joplin R., Gordon L., Lindsay J., et al. Membrane dihydrolipoamide acetyltransferase (E2) on human biliary epithelial cells in primary biliary cirrhosis. Lancet 339 (1992) 93-94
26. Inamura K., Tsuji H., Nakamoto Y., et al. Transgenic mice aberrantly expressing pyruvate dehydrogenase complex E2 component on biliary epithelail cells do not show primary biliary cirrhosis. Clin Exp Immunol 145 (2006) 93-100
27. Kisand K., Kisand K., Salupere V., et al. Enzyme -linked immunosorbent assays for the determination of IgG, IgA, and IgM autoantibodies to pyruvate dehydrogenase in primary biliary cirrhosis. Int J Clin Lab Res 24 (1994) 98-101
28. Jones D.E.J., Palmer J.M., Yeaman S.J., et al. Breakdown of tolerance to pyruvate dehydrogenase complex in experimental autoimmune cholangitis a murine model of primary biliary cirrhosis. Hepatology 30 (1999) 65-70
29. Jones D.E.J., Palmer J.M., Bennett K., et al. Investigation of a mechanism for accelerated breakdown of immune-tolerance to the primary biliary cirrhosis associated autoantigen,pyruvate dehydrogenase complex. Lab Invest 82 (2002) 211-219
30. Jones D.E.J., Robe A.J., Kirby J.A., et al. Adopotive transfer of self-PDC-reactive T-cells into naive mice induces portal tract and bile duct changes characteristic of primary biliary cirrhosis (PBC). J Hepatol 44 (2006) S10
31. Irie J., Wu Y., Wicker L.S., et al. NOD.c3c4 congenic mice develop autoimmune liver disease that serologically and pathogenetically models human primary biliary cirrhosis. J Exp Med 203 (2006) 1209-1219
32. Oertelt S., Lian Z.X., Cheng C.M., et al. Anti-mitochondrial antibodies and primary biliary cirrhosis. J Immunol 177 (2006) 1655-1660
33. Wakabayashi K, Lian ZX, Moritoki Y, et al. IL-2 receptor alpha (-/-) mice and the development of primary biliary cirrhosis. Hepatology 44:1240-9.
34. Gershwin M.E., Chuang Y.-H., Yang G.-X., et al. NOD.2445 mice, a spontaneous model of human primary biliary cirrhosis, develop specific autoreactive T cells. Hepatology 46 (2007) 543A
35. Leung P.S.C., Park O., Tsuneyama K., et al. Induction of primary biliary cirrhosis in guinea pigs following chemical xenobiotic immunization. J Immunol 179 (2007) 2651-2657
36. Lan R.Y., Cheng C., Lian Z.X., et al. Liver-targeted and peripheral blood alterations of regulatroy T-cells in primary biliary cirrhosis. Hepatology 43 (2006) 729-737
37. Teoh K.L., Mackay I.R., Rowley M.J., et al. Enzyme inhibitory autoantibodies to pyruvate dehydrogenase complex in primary biliary cirrhosis differ for mammalian, yeast and bacterial enzymes: implications for molecular mimicry. Hepatology 19 (1994) 1029-1033
38. Long S.A., Quan C., Van de Water J., et al. Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis. J Immunol 167 (2001) 2956-2963
39. Walden H.R., Palmer J.M., Kirby J.A., et al. Substrate promiscuity in the pyruvate dehydrogenase complex (PDC) lipoylation pathway:xenobiotic incorporation as a potential mechanism for the pathogenesis of primary biliary cirrhosis. Hepatology 46 (2007) 545A
40. Prince M.I., Chetwynd A., Diggle P., et al. The geographical distribution of primary biliary cirrhosis in a well-defined cohort. Hepatology 34 (2001) 1083-1088
41. Ala A., Stanca C.M., Bu-Ghanim M., et al. Increased prevalence of primary biliary cirrhosis near Superfund waste sites. Hepatology 43 (2006) 525-531
42. Pasare C., and Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299 (2003) 1033-1036 [comment]
43. Mao T.K., Lian Z.-X., Selmi C., et al. Altered monocyte responses to defined TLR ligands in patient with primary biliary cirrhosis. Hepatology 42 (2005) 802-808
44. Moritoki Y., Lian Z., Wulff H., et al. AMA propduction in primary biliary cirrhosis is promoted by the TLR9 ligand CpG and suppressed by potassium channel blockers. Hepatology 45 (2007) 314-322
45. Haruta I., Hashimoto E., Kato Y., et al. Lipoteichoic acid may affect the pathogenesis of bile duct damage in primary biliary cirrhosis. Autoimmunity 39 (2006) 129-135
46. Sadamoto T., Joplin R., Keogh A., et al. Expression of pyruvate-dehydrogenase complex PDC-E2 on biliary epithelial cells induced by lymph nodes from primary biliary cirrhosis. Lancet 352 (1998) 1595-1596
47. Xu L., Shen S., Guo L., et al. Does a betaretrovirus infection trigger primary biliary cirrhosis?. Proc Natl Acad Sci U S A 100 (2003) 8454-8459
48. Xu L., Sakalian M., Shen Z., et al. Cloning the human betaretrovirus proviral genome form patients with primary biliary cirrhosis. Hepatology 39 (2004) 151-156
49. Selmi C., Ross S.R., Ansari A.A., et al. Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis. Gastroenterology 127 (2004) 493-501
50. Klein R., Wiebel M., Engelhart S., et al. Sera from patients with tuberculosis recognise the M2a-epitope (E2-subunit of pyruvate dehydrogenase complex) specific for primary biliary cirrhosis. Clin Exp Immunol 92 (1993) 308-316
51. Butler P., Valle F., Hamilton-Miller J.M., et al. M2 mitochondrial antbodies and urinary rough mutant bacteris in patients with primary biliary cirrhosis and in patients with recurrent bacteriuria. J Hepatol 17 (1993) 408-414
52. Kuroki T., Seki S., Kawakita N., et al. Expression of antigens related to apoptosis and cell proliferation in chronic nonsuppurative destructive cholangitis in primary biliary cirrhosis. Virchows Arch 429 (1996) 119-129
53. Harada K., Ozaki S., Gershwin M.E., et al. Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis. Hepatology 26 (1997) 1399-1405
54. Tinmouth J., Lee M., Wanless I.R., et al. Apoptosis of biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis. Liver 22 (2002) 228-234
55. Martinez O.M., Villanueva J.C., Gershwin M.E., et al. Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis. Hepatology 21 (1995) 113-119
56. Rodrigues C.M.P., Fan G.S., Ma X.M., et al. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J Clin Invest 101 (1998) 2790-2799
57. Paumgartner G., and Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology 36 (2002) 525-531
58. Ballardini G., Guidi M., Susca M., et al. Bile duct apoptosis is a rare event in primary biliary cirrhosis. Dig Liver Dis 33 (2001) 151-156
59. Onori P., Alvaro A., Floreani A., et al. Activation of the IGF1 system characterizes cholangiocyte survival during progression of primary biliary cirrhosis. J Histochem Cytochem 55 (2007) 327-334
60. Aboutwerat A., Pemberton P.W., Smith A., et al. Oxidant stress is a significant feature of primary biliary cirrhosis. Biochim Biophys Acta 1637 (2003) 142-150
61. Jung Y., McCall S.J., Li Y.X., et al. Bile ductules and stromal cells express hedgehog ligands and/or hedgehog target genes in primary biliary cirrhosis. Hepatology 45 (2007) 1091-1096
62. Lee J.M., Dedhar S., Kalluri R., et al. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 172 (2006) 973-981
63. Wasilenko S., and Mason A.L. New insights from recurrent primary biliary cirrhosis in liver transplantation: the paradox of BEComing a fibroblast. Hepatology 45 (2007) 837-840
64. Xia J.-L., Dai C., Michalopoulos G.K., et al. Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation. Am J Pathol 168 (2006) 1500-1512
65. Sicklick J.K., Choi S.S., Bustamante M., et al. Evidence for epithelial to mesenchymal transition in adult liver cells. Am J Physiol Gastrointest Liver Physiol 291 (2006) G575-G583
66. Rygiel K.A., Robertson H., Burt A.D., et al. Demonstration of the transition of intrahepatic biliary epithelial cells to fibroblasts during chronic inflammatory liver diseases. J Hepatol 44 (2006) S241
67. Robertson H., Kirby J.A., Yip W., et al. Biliary epithelial-mesenchymal transtion in post-transplantation recurrence of primary biliary cirrhosis. Hepatology 45 (2007) 977-981
68. Rygiel K.A., Robertson H., Pekalski M., et al. Epithelial-mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease. Lab Invest 88 (2008) 112-123
69. Kuroiwa T., Iwasaki T., Imado T., et al. Hepatocyte growth factor prevents lupus nephritis in a murine lupus model of chronic graft-versus-host disease. Arthritis Res Ther 8 (2006) R123
70. Sasaki M., Ikeda H., Kataoka H., et al. Augmented expression of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in intrahepatic small bile ducts in primary biliary cirrhosis. Virchows Archiv 449 (2006) 462-471
71. Matsumura S., Van de Water J., Kita H., et al. Contribution to antimitochondrial antibody production: cleavage of pyruvate dehydroganse complex-E2 by apoptosis-related proteases. Hepatology 35 (2002) 14-22
72. Odin J.A., Huebert R.C., Casciola-Rosen L., et al. Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J Clin Invest 108 (2001) 223-232
73. Richardson M.M., Jonsson J.R., Powell E.E., et al. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductual reaction. Gastroenterology 133 (2007) 80-90
74. Theise N.D., and Kuwahara R. The tissue biology of ductular reactions in human chronic liver disease. Gastroenterology 133 (2007) 350-352